SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-022990
Filing Date
2021-05-04
Accepted
2021-05-04 07:32:27
Documents
15
Period of Report
2021-05-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K kldo-8k_20210504.htm   iXBRL 8-K 44566
2 EX-10.1 kldo-ex101_34.htm EX-10.1 128010
3 EX-99.1 kldo-ex991_6.htm EX-99.1 99766
4 GRAPHIC gbsact4ghonl000001.jpg GRAPHIC 4318
  Complete submission text file 0001564590-21-022990.txt   436225

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA kldo-20210504.xsd EX-101.SCH 5772
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE kldo-20210504_lab.xml EX-101.LAB 19459
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kldo-20210504_pre.xml EX-101.PRE 11626
8 EXTRACTED XBRL INSTANCE DOCUMENT kldo-8k_20210504_htm.xml XML 3539
Mailing Address 18 CROSBY DRIVE BEDFORD MA 01730
Business Address 18 CROSBY DRIVE BEDFORD MA 01730 617-674-9000
Kaleido Biosciences, Inc. (Filer) CIK: 0001751299 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38822 | Film No.: 21886007
SIC: 2836 Biological Products, (No Diagnostic Substances)